Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/11/2026

Guidelines for High‑Resolution HLA‑DRB1 Testing in Transplantation

Hematopoietic Stem Cell Transplantation (HSCT)

  • High‑resolution HLA‑DRB1 testing is essential to optimize donor‑recipient matching; mismatches at this locus markedly increase mortality, acute graft‑versus‑host disease, and transplant‑related complications. – Blood 2012 1
  • Unrelated donor selection should include complete high‑resolution typing of HLA‑A, ‑B, ‑C, and ‑DRB1 to identify the best match. – Blood 2012 [1][2]3
  • Mismatches at HLA‑A and HLA‑DRB1 are less tolerated than mismatches at HLA‑B or HLA‑C, making DRB1 matching critical for survival outcomes. – Blood 2012 [2][3]
  • Each additional HLA mismatch reduces survival in a dose‑dependent manner: ≈10 % lower survival per mismatch in low‑risk disease patients and ≈5 % lower in high‑risk disease patients. – Blood 2012 4 (observational cohort; moderate evidence)
  • Cord‑blood units must be typed for HLA‑DRB1 at high resolution (minimum requirement) and HLA‑C typing is strongly recommended. – Blood 2012 [1][3]
  • When two loci are mismatched in cord‑blood transplants, mismatching at HLA‑C and HLA‑DRB1 confers the highest mortality risk. – Blood 2012 7
  • High‑resolution typing characterizes allele‑level mismatches, allowing a more precise evaluation of HLA matching impact. – Blood 2012 [1][3]
  • If a fully matched donor (HLA‑A, ‑B, ‑C, ‑DRB1) cannot be found, additional loci (‑DQB1 and ‑DRB3/4/5) should be typed to select the optimal mismatched donor. – Blood 2012 [1][2]8

Solid Organ Transplantation

Kidney

  • High‑resolution HLA genotyping is recommended (Grade 1A) to accurately assess anti‑HLA antibody specificity to the donor. – American Journal of Transplantation 2023 9
  • This testing enables precise identification of donor‑specific antibodies that predict antibody‑mediated rejection and graft loss. – American Journal of Transplantation 2023 9

Liver

  • High‑resolution HLA‑DRB1 genotyping is recommended (Grade 2C) for post‑transplant donor‑specific antibody assessment. – American Journal of Transplantation 2023 9
  • Complement‑fixing donor‑specific antibodies are associated with an increased risk of allograft loss and rejection. – American Journal of Transplantation 2023 9

Heart & Lung

  • High‑resolution HLA genotyping (Grade 1B) is recommended for accurate anti‑HLA antibody specificity assessment in both heart and lung transplantation. – American Journal of Transplantation 2023 9

Technical Principles of High‑Resolution Typing

  • High‑resolution typing targets alleles that encode the cell‑surface proteins and the antigen‑recognition site (ARS) of HLA molecules. – Blood 2012 [1][2]
  • The ARS is the functional region that binds peptide antigens and interacts with T‑cell receptors. – Blood 2012 [1][2]
  • Alleles identical in the ARS domain are immunologically equivalent and are considered matched. – Blood 2012 [1][2]

Clinical Context Influencing Testing Strategy

  • HLA mismatching has a greater adverse impact on mortality in early‑stage/low‑risk disease recipients compared with intermediate‑stage or advanced disease patients. – Blood 2012 [8][10]11
  • In advanced disease where rapid transplantation is required, a higher degree of mismatching may be acceptable. – Blood 2012 [8][10]

Common Pitfalls to Avoid

  • Do not rely solely on antigen‑level typing for HLA‑DRB1; allele‑level mismatches produce adverse effects comparable to antigen‑level mismatches. – Blood 2012 4
  • Do not delay urgent transplantation; balance the cost and turnaround time of high‑resolution typing against clinical urgency, possibly using targeted‑loci screening strategies. – Blood 2012 [1][8]
  • Do not assume that matching HLA‑DRB1 alone is sufficient; comprehensive matching of HLA‑A, ‑B, ‑C, and ‑DRB1 is required for optimal outcomes. – Blood 2012 [1][2]4
  • Do not overlook cost considerations; involve HLA‑expert assistance to focus resources on donors most likely to achieve a high‑resolution match. – Blood 2012 [8][10]